Veerhealth Care Limited - 511523 - Results-Financial Results For December 31, 2023
Please find attached Financial Results for the quarter and nine months ended 31st December, 2023.10-02-2024
10-02-2024
Veerhealth Care Limited - 511523 - Board Meeting Outcome for Outcome Of Board Meeting
This is to inform you that the Board of Directors of the Company at its meeting held today, i. e. 10th February, 2024, inter alia, has approved the following: 1. The Board has approved and taken on record the unaudited financial results for the quarter and nine months ended December 31, 2023. 2. For meeting exports and local demand, Board has decided to increase manufacturing capacity, and to meet such capex, Board has decided to raise funds by way of preferential offer, rights issue or such other methods or combinations as may be considered appropriate. The Board Meeting commenced at 3.00 p.m. and concluded at 4.00 p.m.10-02-2024
Veerhealth Care Limited - 511523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Management team of the Company shall be participating in Q3 FY24 earnings call scheduled on Tuesday, February 13, 2024 at 11.00 am (IST) hosted by Kirin Advisors. Please find attached details of the invitation.09-02-2024
Veerhealth Care Limited - 511523 - Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On Saturday, 10Th February, 2024
Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 ,inter alia, to consider and approve 1. Unaudited financial results of the Company for the quarter and nine months ended 31st December, 2023. 2. Company is planning to do expansion and to meet up those Capital Expenditure, to consider capital raising options for the Company, as the Board may deem appropriate.02-02-2024
Veerhealth Care Limited - 511523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Veerhealth Care Limited is proud to announce that the Company have been allotted Labeler Code from US FDA. Please find enclosed herewith a copy of Press Release giving information about the same.30-01-2024
Veerhealth Care Limited - 511523 - Announcement Under Regulation 30 (LODR) - Allotment Of Labeler Code By United States (US) FDA
Veerhealth Care Limited is proud to announce that the Company have been allotted Labeler Code from US FDA. As per Section 510 of the Federal Food, Drug and Cosmetic, Act (Act), 21 U.S.C. 360: "Drug products are identified and reported using a unique, three-segment number, called the National Drug Code (NDC), which is a universal product identifier for human drugs. Each listed drug product is assigned a unique 10-digit, 3-segment number. This number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the Labeler Code, is assigned by the US FDA. With the allotment of Labeler Code, now Company will be eligible to expand the business to various customers of the institutional supply industry in US market. With this new avenue of entry in the US market, Company is expecting additional growth in turnover with approximately 10% Profit after Tax from the next financial year.29-01-2024
Veerhealth Care Limited - 511523 - Announcement Under Regulation 30 (LODR) - Successful Registration Of Products On Government E-Marketplace (Gem) Portal
Company has successfully completed Quality Council of India inspection for the onboarding process on the Government e-Marketplace (GeM) portal. Company has been registered as OEM for 9 product covering skin care, body care & hair care categories. Government e-Marketplace (GeM) is the National Public Procurement Portal; an end-to-end online Marketplace for Central and State Government Ministries / Departments, Central & State Public Sector Undertakings, Autonomous institutions and local bodies, for procurement of common use goods & services. Company is now eligible to bid for tenders pertaining to personal care category on Government e-Marketplace (GeM) portal. Company is expecting to get substantial addition to current revenues with approximately 10% Profit after Tax from the next financial year.12-01-2024
Veerhealth Care Limited - 511523 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018, we are hereby submitting the certificate for the quarter ended 31st December, 2023.03-01-2024
Veerhealth Care Limited - 511523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Veerhealth Care Limited is proud to announce, that the Company has received a Preliminary Sample Export Order worth US$ 50,000 (Rs. 41.50 Lakhs Approx.) from one of the top institutional supplier company in the United States of America. Please find enclosed herewith a copy of Press Release giving information about the same.02-01-2024
Veerhealth Care Limited - 511523 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order
Veerhealth Care Limited is proud to announce that the Company has received a preliminary sample export order worth US$ 50,000 (Rs. 41.50 Lakhs Approx.) from one of the top institutional supplier company in the United States of America. Company has been successfully manufacturing and exporting various types of oral care products to East African countries and now Company will be entering USA market which would open up other markets worldwide for the manufacturing and supply of Oral Care Products.01-01-2024